Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Echo Therapeutics Inc

+ Add to Watchlist

XS5A:GR

1.402 EUR 0.043 2.98%

As of 15:44:34 ET on 05/22/2015.

Snapshot for Echo Therapeutics Inc (XS5A)

Open: 1.502 Day's Range: 1.377 - 1.502 Volume: 0
Previous Close: 1.445 52wk Range: 0.250 - 2.750 1-Yr Rtn: +15.87%

Stock Chart for XS5A

No chart data available.
  • XS5A:GR 1.502
  • 1D
  • 1M
  • 1Y
1.445
Interactive XS5A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XS5A

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 15.60
Shares Outstanding (M) 11.13
30 Day Average Volume 94
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XS5A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XS5A

Echo Therapeutics Inc. is a specialty transdermal therapeutics and diagnostics company. The Company develops portfolio of topical formulations of established, FDA approved products using its proprietary Azone dermal penetration technology.

Michael M GoldbergChairmanScott W HollanderPresident/CEO
Alan W SchoenbartCFO/SecretaryChristine H OlimpioDir:Investor Relations
More Company Profile & Key Executives for XS5A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil